Citation Impact
Citing Papers
Altered parvalbumin-positive neuron distribution in basal ganglia of individuals with Tourette syndrome
2005
Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance
2014 StandoutNobel
A controlled trial of antidepressants in patients with Parkinson disease and depression
2008
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Adrenergic α2C-Receptors Modulate the Acoustic Startle Reflex, Prepulse Inhibition, and Aggression in Mice
1998 StandoutNobel
Critical period plasticity in local cortical circuits
2005 Standout
Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey
2008
Differential clinical and motor control function in a pair of monozygotic twins with Huntington's disease
1999
Influences of sensation seeking, gender, risk appraisal, and situational motivation on smoking
1990
Parkinson's disease
2021 Standout
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder
2001
Systematic Review of the Prevalence and Incidence of Parkinson’s Disease in Asia
2009
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Vascular dementia
2015 Standout
Differences in duration of Huntington's disease based on age at onset
1999
Excitotoxic Neuronal Death and the Pathogenesis of Huntington's Disease
2008
Structural basis for triplet repeat disorders: a computational analysis
1999 StandoutNobel
Huntington's disease
2007 Standout
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
2004 Standout
Cognitive Dysfunction Precedes Neuropathology and Motor Abnormalities in the YAC128 Mouse Model of Huntington's Disease
2005
Is depression in Parkinson's Disease (PD) a specific entity?
2011
Alzheimer's disease
2011 Standout
Factors associated with depression in Parkinson's disease
2011
The contribution of the study of neurodegenerative disorders to the understanding of human memory
2004
Stress and Alcohol Interaction: An Update of Human Research
1991
Parkinson's disease: clinical features and diagnosis
2008 Standout
Parkinson's disease and sleep
2003
Huntington’s disease
2006
Guanfacine Treatment of Comorbid Attention-Deficit Hyperactivity Disorder and Tourette's Syndrome: Preliminary Clinical Experience
1995
Epidemiology of Parkinson's disease
2006 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Monetary Costs of Dementia in the United States
2013 Standout
An atlas of genetic correlations across human diseases and traits
2015 Standout
Mapping anterior temporal lobe language areas with fMRI: A multicenter normative study
2010
A stress response pathway regulates DNA damage through β2-adrenoreceptors and β-arrestin-1
2011 StandoutNatureNobel
Alterations in opioid receptor binding in Parkinson's disease patients with levodopa‐induced dyskinesias
1997
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The WU-Minn Human Connectome Project: An overview
2013 Standout
What makes us tick? Functional and neural mechanisms of interval timing
2005 Standout
Clinical potential of minocycline for neurodegenerative disorders
2004
Accounting for the effects of accountability.
1999 Standout
Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course
2003
NOVEL DRUGS FOR PARKINSON'S DISEASE
1999
From mice to men: What can we learn about personality from animal research?
2001 Standout
Microglial activation in presymptomatic Huntington's disease gene carriers
2007
A Five-Year Study of the Incidence of Dyskinesia in Patients with Early Parkinson's Disease Who Were Treated with Ropinirole or Levodopa
2000 Standout
Parkinson's disease
2015 Standout
Fish Intake, Contaminants, and Human Health
2006 Standout
Blood pressure and the risk for dementia—A double edged sword
2008
Humanized Foxp2 specifically affects cortico-basal ganglia circuits
2010 StandoutNobel
Alzheimer's Disease
2010 Standout
Parkinson's Disease
1998 Standout
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Non-motor features of Parkinson disease
2017 Standout
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
SURGERY FOR MOVEMENT DISORDERS
2008
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
d-amphetamine and l-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the α2C-adrenergic receptor subtype
1998 StandoutNobel
Huntington's Disease and Related Disorders
2005
Neurodegenerative diseases and oxidative stress
2004 Standout
From inflammation to sickness and depression: when the immune system subjugates the brain
2007 Standout
Neurobiological issues in Tourette syndrome
1994
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
The projected effect of risk factor reduction on Alzheimer's disease prevalence
2011 Standout
The age-dependent relation of blood pressure to cognitive function and dementia
2005
Dementia associated with Parkinson's disease
2003
Meditation states and traits: EEG, ERP, and neuroimaging studies.
2006 Standout
Selective Neuronal Degeneration in Huntington's Disease
2006
Frailty in elderly people
2013 Standout
How do heart disease and stroke become risk factors for Alzheimer's disease?
2006
The origin of extracellular fields and currents — EEG, ECoG, LFP and spikes
2012 Standout
Depression in Older Adults
2009 Standout
Huntington??s Disease
1999
Trials of pharmacological interventions for Tourette syndrome: a systematic review.
2013
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
2009
Risk and Religion: An Explanation of Gender Differences in Religiosity
1995
Gender differences in risk taking: A meta-analysis.
1999 Standout
RELIGIOUS AND MYSTICAL STATES: A NEUROPSYCHOLOGICAL MODEL
1993
Heterozygous α 2A -adrenergic receptor mice unveil unique therapeutic benefits of partial agonists
2002 StandoutNobel
fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's Disease.
2005
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Motivational factors in decision theories: The role of self-protection.
1993
Awareness of Involuntary Movements in Huntington Disease
1998
Habits, Rituals, and the Evaluative Brain
2008
Mutation of the α2A-Adrenoceptor Impairs Working Memory Performance and Annuls Cognitive Enhancement by Guanfacine
2002 StandoutNobel
Targets for the Prevention of Dementia
2010
The Psychophysiology of Sensation Seeking
1990
The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer’s and Parkinson’s diseases1,2 11Guest Editors: Mark A. Smith and George Perry 22This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.
2002
Cannabinoids for Medical Use
2015 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Review: Blood pressure and dementia — a comprehensive review
2009
Clonidine
1996
Antioxidants as treatment for neurodegenerative disorders
2002
Objective assessment of progression in Huntington’s disease: A 3-year follow-up study
2001
Therapeutic Effects of Coenzyme Q10and Remacemide in Transgenic Mouse Models of Huntington's Disease
2002
The prevalence of Parkinson's disease: A systematic review and meta‐analysis
2014 Standout
Huntington’s disease
2003
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
2003 StandoutScience
Long chain polyunsaturated fatty acid supplementation in infants born at term
2017
Anti-Hypertensive Medication Use and Incident Alzheimer's Disease. The Cache County Study
2006
Urate: A Novel Biomarker of Parkinson‘s Disease Risk, Diagnosis and Prognosis
2010
How common are the “common” neurologic disorders?
2007
Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030
2006 Standout
Sensation seeking: A comparative approach to a human trait
1984
Cannabinoids for Tourette's Syndrome
2009
Works of Peter G. Como being referenced
Tourette's syndrome in a special education population
1994
Functional decline in Huntington's disease
1995
Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case-control study
2006
A controlled trial of fluoxetine in nondepressed patients with Huntington's disease
1997
Relationship between blood pressure and Alzheimer's disease in Linxian County, China
2003
A controlled trial of propoxyphene and naltrexone in patients with tourette's syndrome
1991
Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome
2006
The course of depressive symptoms in early Parkinson's disease
2009
A controlled trial of remacemide hydrochloride in Huntington's disease
1996
Segregation and Linkage Analyses of Tourette's Syndrome and Related Disorders
1990
Assessment of coenzyme q10 tolerability in huntington's disease
1996
A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder
1996
Prevalence of dementia in rural China: impact of age, gender and education
2006
The prevalence of PD in a nutritionally deficient rural population in China
2005
Infant formula and neurocognitive outcomes: impact of study end-point selection
2015
Electrophysiological and behavioral correlates of arousal
1981
Preliminary examination of the comorbidity of anxiety and depression in Parkinson's disease
1992
Sensation seeking and arousal systems
1983
Predicting verbal memory decline following anterior temporal lobectomy (ATL)
2003
Sensation seeking and stimulus intensity as modulators of cortical, cardiovascular, and electrodermal response: A cross-modality study
1988
Prevalence of tics in schoolchildren and association with placement in special education
2001
The early course of the Tourette's syndrome clinical spectrum
1993
Clonidine and Gilles de la Tourette's syndrome: Double‐blind study using objective rating methods
1987
Memory failure in huntington's disease
1987
The impact of depressive symptoms in early Parkinson disease
2007
Clinical markers of early disease in persons near onset of Huntington’s disease
2001
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease
1994
Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort
2009